.png){kind=small}
.png){kind=small}
BackTable / Tumor Board / Podcast / Episode #12
Tumor Board: Multidisciplinary Management of Testicular Germ Cell Tumors
with Dr. Nabil Adra and Dr. Richard Matulewicz
What does it take to deliver truly personalized, multidisciplinary care in testicular cancer? Get an inside look in this episode of BackTable Tumor Board, where renowned testicular cancer experts Dr. Nabil Adra and Dr. Richard Matulewicz join host Dr. Aditya Bagrodia for a virtual tumor board session on the nuanced management of germ cell tumors.
This podcast is supported by:
Be part of the conversation. Put your sponsored messaging on this episode. Learn how.
BackTable, LLC (Producer). (2025, May 27). Ep. 12 – Tumor Board: Multidisciplinary Management of Testicular Germ Cell Tumors [Audio podcast]. Retrieved from https://www.backtable.com
Stay Up To Date
Follow:
Subscribe:
Sign Up:
Podcast Contributors
Dr. Nabil Adra
Dr. Nabil Adra is a hematologist and Associate Professor of Clinical Medicine and Urology at Indiana University Health in Indianapolis, Indiana.
Dr. Richard Matulewicz
Dr. Richard Matulewicz is a urologic oncologist and surgeon at Memorial Sloan Kettering Cancer Center in New York City.
Dr. Aditya Bagrodia
Dr. Aditya Bagrodia is an associate professor of urology and genitourinary oncology team leader at UC San Diego Health in California and adjunct professor of urology at UT Southwestern.
Synopsis
The expert panel uses specific patient cases to review their decision-making processes on the use of surgery, chemotherapy, and radiation. They highlight the importance of a multidisciplinary approach, particularly for advanced disease and challenging surgical scenarios. The episode reviews patient-specific factors, standard treatment protocols, post-treatment surveillance, and the latest research. This episode also highlights the benefits of personalized cancer care.
Timestamps
00:00 - Case Presentation: 23-Year-Old Male with Testicular Mass
09:53 - Surveillance vs. Adjuvant Therapy Debate
13:53 - Recurrence, Comprehensive Staging, and Next Steps
23:09 - Case Study: 44-Year-Old with Mixed Non-Seminoma Germ Cell Tumor
27:47 - Surveillance and Surgery Recommendations
28:11 - Case Study: 17-Year-Old with Developmental Delay and Cancer
30:10 - Chemotherapy, Surgical Timing, and Prognosis
44:58 - Case Study: 21-Year-Old with Scrotal Swelling
47:12 - Surgical Considerations and Multidisciplinary Approach
Resources
Society of Urologic Oncology
https://suonet.org/home.aspx
Disclaimer: The Materials available on BackTable.com are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.
Up Next
